Aquilo Capital Management, LLC, 10% Owner at Spero Therapeutics, Inc. (SPRO), bought 325,986 shares at $15.75 ($5.0M) on 2021-12-31, disclosed to the SEC on 2022-01-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.64 | 75,493 | $1.1M | 22.2% |
| 2 | $14.64 | 75,493 | $1.1M | 22.2% |
| 3 | $15.77 | 50,000 | $789K | 15.9% |
| 4 | $15.75 | 125,000 | $2.0M | 39.6% |
| Total | $15.24 avg | 325,986 | $5.0M | 100% |
| Filing → |
| SPRO | BUY | 2022-02-23 | $274K | — | Filing → |
| SPRO | BUY | 2022-02-01 | $1.4M | — | Filing → |
| SPRO | BUY | 2022-01-20 | $1.2M | — | Filing → |